Quantedge Capital
TXG icon

Quantedge Capital’s 10x Genomics TXG Stock Holding History

Quantedge Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-80,953
Closed -$3.1M – 74
2026
Q2 		$3.1M Sell
80,953
-335,600
-81% -$8.79M 2.35% 14
2026
Q1 		$8.84M Buy
416,553
+212,600
+104% +$4.25M 4.84% 4
2025
Q4 		$3.33M Buy
+203,953
New +$3.08M 1.59% 17

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Quantedge Capital's TXG Position: Q3 2026 in Review

Quantedge Capital sold out of 10x Genomics (TXG) in Q3 2026, closing a stake of 80,953 shares — an estimated $3.1M sold.

Quantedge Capital first reported a position in TXG in Q4 2025 and held it in 3 quarters. The position peaked at $8.84M in Q1 2026. 305 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Quantedge Capital reported no remaining 10x Genomics position as of Q3 2026 after selling out during the quarter.
  • Quantedge Capital sold 80,953 10x Genomics shares in Q3 2026, an estimated $3.1M.
  • Quantedge Capital first reported a position in 10x Genomics in Q4 2025 and held it in 3 quarters.
  • Quantedge Capital's 10x Genomics position peaked at $8.84M in Q1 2026.
  • 305 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Quantedge Capital's 13F filing for Q3 2026, filed 10 Nov 2026.